Gaurav Munj 2022-03-04T06:42:16+00:00 CREATING SHAREHOLDER VALUE Site - Investor Relations Nav Overview Press Releases Events and Presentations Financial Filings Stock Information Corporate Governance Contact Upcoming and Recent Events Corporate Presentation SEC Filings Stock Quote & Chart Historical Lookup Governance Documents Committees Biohaven is a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas including neuroscience, immunology and oncology. Latest Press Releases August 8, 2024 Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments May 29, 2024 Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day View All Press Releases View All Events May 29, 2024 Biohaven R&D Day at Yale School of Management May 31, 2023 Biohaven R&D Day at Yale School of Management March 13 - March 15, 2023 2023 American Society for Experimental Neurotherapeutics Annual Meeting (ASENT 2023) View All Events View All BIOHAVEN EVENTS CORPORATE PRESENTATION LETTER FROM THE CHAIRMAN & CEO VIDEOS play video INTERVIEW WITH CEO VLAD CORIC M.D. ON CNBC’S FAST MONEY x play video Interview with CEO Vlad Coric M.D. on CNBC’s Mad Money x play video Diseases related to glutamate dysregulation x
Biohaven is a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas including neuroscience, immunology and oncology. Latest Press Releases August 8, 2024 Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments May 29, 2024 Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day View All Press Releases View All Events May 29, 2024 Biohaven R&D Day at Yale School of Management May 31, 2023 Biohaven R&D Day at Yale School of Management March 13 - March 15, 2023 2023 American Society for Experimental Neurotherapeutics Annual Meeting (ASENT 2023) View All Events View All BIOHAVEN EVENTS CORPORATE PRESENTATION LETTER FROM THE CHAIRMAN & CEO VIDEOS play video INTERVIEW WITH CEO VLAD CORIC M.D. ON CNBC’S FAST MONEY x play video Interview with CEO Vlad Coric M.D. on CNBC’s Mad Money x play video Diseases related to glutamate dysregulation x
August 8, 2024 Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments
May 29, 2024 Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day
March 13 - March 15, 2023 2023 American Society for Experimental Neurotherapeutics Annual Meeting (ASENT 2023)